Skip to content

Colorado Prevention Center

Boston Business Watch reported on Colorado Prevention Center on October 7, 2026.

What we have reported

  1. October 7, 2026

    Boston Biotech Rezera Says Its Pill Boosts Semaglutide's Anti-Inflammatory Effect

    Rezera reported positive Phase 2 results on October 7, 2026 for ruvonoflast combined with semaglutide in 82 adults with obesity.